TRACON Pharmaceuticals (TCON) Insider Trading & Ownership → New Trump Bombshell (From The Freeport Society) (Ad) Free TCON Stock Alerts $1.81 +0.10 (+5.85%) (As of 05/2/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media TRACON Pharmaceuticals (NASDAQ:TCON) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.27%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$2.98 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$2,188.80 Get TCON Insider Trade Alerts Want to know when executives and insiders are buying or selling TRACON Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TCON Insider Buying and Selling by Quarter Ad The Freeport SocietyNew Trump BombshellI believe Donald J. Trump will go down as America’s last Republican president. But NOT for the reasons you may think… Click here to see my 2024 election prediction. TRACON Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/26/2023Charles TheuerCEOBuy199$13.20$2,626.80 3/9/2023Opaleye Management Inc.Major ShareholderBuy8,725$27.60$240,810.00 2/28/2023Charles TheuerCEOBuy10$30.40$304.00 1/18/2023Charles TheuerCEOBuy340$32.40$11,016.00 12/14/2022Charles TheuerCEOBuy1,150$25.80$29,670.00 12/14/2022Opaleye Management Inc.Major ShareholderBuy8,375$25.00$209,375.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/6/2022Opaleye Management Inc.Major ShareholderSell76$28.80$2,188.80 11/18/2022Charles TheuerCEOBuy695$28.20$19,599.00 11/2/2022Charles TheuerCEOBuy300$31.80$9,540.00 10/18/2022Opaleye Management Inc.Major ShareholderBuy625$33.00$20,625.00 10/7/2022Charles TheuerCEOBuy250$35.40$8,850.00 10/3/2022Charles TheuerCEOBuy250$33.40$8,350.00 9/29/2022Opaleye Management Inc.Major ShareholderBuy470$34.80$16,356.00 9/27/2022Opaleye Management Inc.Major ShareholderBuy85$33.80$2,873.00 9/22/2022Charles TheuerCEOBuy250$35.20$8,800.00 9/22/2022Opaleye Management Inc.Major ShareholderBuy865$34.60$29,929.00 9/19/2022Opaleye Management Inc.Major ShareholderBuy250$37.40$9,350.00 9/12/2022Scott B BrownCFOBuy125$40.40$5,050.00 7/26/2022Opaleye Management Inc.Major ShareholderBuy112$34.40$3,852.80 7/22/2022Charles TheuerCEOBuy225$37.00$8,325.00 7/14/2022Opaleye Management Inc.Major ShareholderBuy359$36.20$12,995.80 7/12/2022Charles TheuerCEOBuy150$37.40$5,610.00 6/24/2022Opaleye Management Inc.Major ShareholderBuy570$27.80$15,846.00 6/21/2022Opaleye Management Inc.Major ShareholderBuy42,099$26.20$1,102,993.80 5/10/2022Opaleye Management Inc.Major ShareholderBuy485$35.20$17,072.00 5/9/2022Charles TheuerCEOBuy500$37.00$18,500.00 5/6/2022Charles TheuerCEOBuy125$39.40$4,925.00 4/29/2022Charles TheuerCEOBuy250$39.40$9,850.00 4/25/2022Opaleye Management Inc.Major ShareholderBuy538$43.60$23,456.80 4/22/2022Opaleye Management Inc.Major ShareholderBuy2,100$44.80$94,080.00 4/21/2022Charles TheuerCEOBuy225$46.00$10,350.00 4/13/2022Opaleye Management Inc.Major ShareholderBuy367$50.00$18,350.00 4/11/2022Opaleye Management Inc.Major ShareholderBuy455$48.40$22,022.00 4/8/2022Charles TheuerCEOBuy100$50.00$5,000.00 3/30/2022Charles TheuerCEOBuy200$54.00$10,800.00 3/29/2022Scott B BrownCFOBuy50$56.40$2,820.00 3/21/2022Charles TheuerCEOBuy60$49.00$2,940.00 1/28/2022Opaleye Management Inc.Major ShareholderBuy25$44.00$1,100.00 1/24/2022Opaleye Management Inc.Major ShareholderBuy868$41.00$35,588.00 1/21/2022Opaleye Management Inc.Major ShareholderBuy1,750$43.80$76,650.00 New Trump Bombshell (Ad)I believe Donald J. Trump will go down as America’s last Republican president. But NOT for the reasons you may think… Click here to see my 2024 election prediction.1/19/2022Opaleye Management Inc.Major ShareholderBuy1,184$44.80$53,043.20 12/29/2021Opaleye Management Inc.Major ShareholderBuy2,616$50.20$131,323.20 12/27/2021Opaleye Management Inc.Major ShareholderBuy4,366$58.40$254,974.40 12/15/2021Opaleye Management Inc.Major ShareholderBuy1,098$48.60$53,362.80 12/13/2021Opaleye Management Inc.Major ShareholderBuy760$52.80$40,128.00 12/6/2021Opaleye Management Inc.Major ShareholderBuy1,136$45.20$51,347.20 12/3/2021Opaleye Management Inc.Major ShareholderBuy4,463$46.00$205,298.00 11/18/2021Charles TheuerCEOBuy34$57.60$1,958.40 11/5/2021Charles TheuerCEOBuy200$68.20$13,640.00 8/16/2021Charles TheuerCEOBuy150$71.20$10,680.00 7/26/2021Saundra L PelletierDirectorBuy327$76.40$24,982.80 (Data available from 1/1/2013 forward) TCON Insider Trading Activity - Frequently Asked Questions Who is on TRACON Pharmaceuticals's Insider Roster? The list of insiders at TRACON Pharmaceuticals includes Charles Theuer, Opaleye Management Inc., Saundra L Pelletier, and Scott B Brown. Learn more on insiders at TCON. What percentage of TRACON Pharmaceuticals stock is owned by insiders? 5.27% of TRACON Pharmaceuticals stock is owned by insiders. Learn more on TCON's insider holdings. Which TRACON Pharmaceuticals insiders have been buying company stock? The following insiders have purchased TCON shares in the last 24 months: Charles Theuer ($136,115.80), Opaleye Management Inc. ($1,682,078.40), and Scott B Brown ($5,050.00). How much insider buying is happening at TRACON Pharmaceuticals? Insiders have purchased a total of 67,589 TCON shares in the last 24 months for a total of $1,823,244.20 bought. Which TRACON Pharmaceuticals insiders have been selling company stock? The following insider sold TCON shares in the last 24 months: Opaleye Management Inc. ($2,188.80). How much insider selling is happening at TRACON Pharmaceuticals? Insiders have sold a total of 76 TRACON Pharmaceuticals shares in the last 24 months for a total of $2,188.80 sold. More Insider Trading Tools from MarketBeat Related Companies: Finch Therapeutics Group Insider Buying Kiromic BioPharma Insider Buying Palisade Bio Insider Buying Fresh Tracks Therapeutics Insider Buying Eloxx Pharmaceuticals Insider Buying Gamida Cell Insider Buying Creative Medical Technology Insider Buying Titan Pharmaceuticals Insider Buying SQZ Biotechnologies Insider Buying TC Biopharm Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:TCON) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
